Security key
09260E105
BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value (BMEZ)
CUSIP: 09260E105
Q3 2020 13F Holders as of 30 Sep 2020
- Security type / class
- Equity / Common Shares, $0.001 par value
- Total 13F shares
- 11,393,980
- Total 13F value
- $271,777,833
- Share change
- +3,478,162
- SEC-reported price per share
- $23.85
- Number of holders
- 44
- Value change
- +$83,226,929
- Number of buys
- 37
- Number of sells
- 11
- Shares outstanding
- 103,858,423
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2020
Institutions
44
Top holders
10
BMEZ full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
BlackRock Health Sciences Term Trust SEC filings
Broader feeds
Reporting periods
Holder history for CUSIP 09260E105
Recent filing periods:
Ownership snapshot
Top reported holders of BMEZ - BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MORGAN STANLEY
Disclosed value leader
MORGAN STANLEY
Comparable rows
0/15
Latest evidence
30 Jun 2020
13F
Highest disclosed value: $70,487,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
MORGAN STANLEY has the largest disclosed position value at $70.49M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MORGAN STANLEY's linked filing trail.
Disclosed position value
Top 5
MORGAN STANLEY
$70.49M
UBS Group AG
$30.71M
BANK OF AMERICA CORP /DE/
$23.61M
RAYMOND JAMES & ASSOCIATES
$12.98M
WELLS FARGO & COMPANY/MN
$5.1M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$70,487,000
3,370,972 shares
|
— | 30 Jun 2020 |
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$30,714,000
1,468,888 shares
|
— | 30 Jun 2020 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
—
denominator unverified
|
$23,614,000
1,129,338 shares
|
— | 30 Jun 2020 |
| RAYMOND JAMES & ASSOCIATES |
13F
Company
|
—
denominator unverified
|
$12,977,000
620,629 shares
|
— | 30 Jun 2020 |
| WELLS FARGO & COMPANY/MN |
13F
Company
|
—
denominator unverified
|
$5,099,000
243,865 shares
|
— | 30 Jun 2020 |
| STIFEL FINANCIAL CORP |
13F
Company
|
—
denominator unverified
|
$2,730,000
130,546 shares
|
— | 30 Jun 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
44
Shares
11,393,980
Rows available
44
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2020 vs Q2 2026 Across Filers
Q2 2026 holders
85
Q3 2020 holders
44
Holder diff
-41
| Investor | Q2 2026 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend